Which super funds hold Keenova Therapeutics PLC?
As at 31 December 2025, 8 Australian super investment options in our dataset held Keenova Therapeutics PLC, the largest weighting being 0.00% in Balanced (Accumulation) (AustralianSuper).
Options holding it
8
Largest weighting
0.00%
Balanced (Accumulation) · AustralianSuper
Australian super investment options disclosing a holding in Keenova Therapeutics PLC. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.
| Fund | Phase | Option | Weighting | Value (AUD) | As at |
|---|---|---|---|---|---|
| AustralianSuper | Accumulation | Balanced (Accumulation) | 0.00% | $79,378 | 31 December 2025 |
| AustralianSuper | Retirement | Balanced (Income) | 0.00% | $10,355 | 31 December 2025 |
| AustralianSuper | Accumulation | High Growth (Accumulation) | 0.00% | $8,880 | 31 December 2025 |
| AustralianSuper | Retirement | Conservative Balanced (Income) | 0.00% | $5,602 | 31 December 2025 |
| AustralianSuper | Accumulation | Conservative Balanced (Accumulation) | 0.00% | $4,679 | 31 December 2025 |
| AustralianSuper | Accumulation | Stable (Accumulation) | 0.00% | $3,290 | 31 December 2025 |
| AustralianSuper | Retirement | Stable (Income) | 0.00% | $3,028 | 31 December 2025 |
| AustralianSuper | Retirement | High Growth (Income) | 0.00% | $593 | 31 December 2025 |
This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.
Methodology — how holdings are sourced, resolved and aggregated.